{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:03:45Z","timestamp":1770915825339,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"9183","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1016\/s0140-6736(98)11282-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:42:52Z","timestamp":1027611772000},"page":"975-978","source":"Crossref","is-referenced-by-count":213,"title":["Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA"],"prefix":"10.1016","volume":"354","author":[{"given":"Nick M","family":"Makridakis","sequence":"first","affiliation":[]},{"given":"Ronald K","family":"Ross","sequence":"additional","affiliation":[]},{"given":"Malcolm C","family":"Pike","sequence":"additional","affiliation":[]},{"given":"Laura E","family":"Crocitto","sequence":"additional","affiliation":[]},{"given":"Laurence N","family":"Kolonel","sequence":"additional","affiliation":[]},{"given":"C Leigh","family":"Pearce","sequence":"additional","affiliation":[]},{"given":"Brian E","family":"Henderson","sequence":"additional","affiliation":[]},{"given":"Jurgen KV","family":"Reichardt","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(98)11282-5_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","article-title":"Cancer statistics, 1998","volume":"48","author":"Landis","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S0140-6736(98)11282-5_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0959-8049(96)00492-3","article-title":"Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990","volume":"73","author":"Black","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(98)11282-5_bib3","first-page":"293","article-title":"Studies on prostatic cancer","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)11282-5_bib4","first-page":"3232","article-title":"Endogenous hormones as a major factor in human cancer","volume":"42","author":"Henderson","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)11282-5_bib5","first-page":"4497","article-title":"Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility","volume":"58","author":"Ross","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)11282-5_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(98)11282-5_bib7","first-page":"1020","article-title":"A prevalent missense substitution that modulates activity of prostatic steroid 5\u03b1-reductase","volume":"57","author":"Makridakis","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)11282-5_bib8","doi-asserted-by":"crossref","unstructured":"Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (in press).","DOI":"10.1093\/oxfordjournals.aje.a010213"},{"key":"10.1016\/S0140-6736(98)11282-5_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.me.42.020191.000301","article-title":"The diagnosis and treatment of prostate cancer","volume":"42","author":"Andriole","year":"1991","journal-title":"Annu Rev Med"},{"key":"10.1016\/S0140-6736(98)11282-5_bib10","series-title":"Comprehensive textbook of genitourinary oncology","first-page":"712","article-title":"Staging systems and prognostic factors for prostate cancer","author":"Montie","year":"1996"},{"key":"10.1016\/S0140-6736(98)11282-5_bib11","first-page":"10","article-title":"1992 staging system for prostate cancer","volume":"11","author":"Montie","year":"1993","journal-title":"Semin Urol"},{"key":"10.1016\/S0140-6736(98)11282-5_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","article-title":"Proportion of disease caused by or prevented by given exposure, trait or intervention","volume":"99","author":"Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0140-6736(98)11282-5_bib13","series-title":"Current protocols in molecular biology","year":"1995"},{"key":"10.1016\/S0140-6736(98)11282-5_bib14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/bi00171a029","article-title":"Natural mutagenesis of the human steroid 5\u03b1-reductase isozyme","volume":"33","author":"Wigley","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/S0140-6736(98)11282-5_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1097-0045(1996)6+<82::AID-PROS16>3.0.CO;2-N","article-title":"5\u03b1-reductase inhibitors\/finasteride","volume":"6","author":"Stoner","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/S0140-6736(98)11282-5_bib16","first-page":"3973","article-title":"Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk","volume":"55","author":"Reichardt","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)11282-5_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/hmg\/2.6.820","article-title":"Unusual length polymorphism in human steroid 5\u03b1-reductase type 2 gene","volume":"2","author":"Davis","year":"1993","journal-title":"(SRD5A2). Hum Mol Genet"},{"key":"10.1016\/S0140-6736(98)11282-5_bib18","first-page":"189","article-title":"A polymorphism of the 5\u03b1-reductase gene and its association with prostate cancer: a case-control analysis","volume":"6","author":"Kantoff","year":"1997","journal-title":"Cancer Epidem Biomark Prev"},{"key":"10.1016\/S0140-6736(98)11282-5_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI115954","article-title":"Molecular genetics of steroid 5\u03b1-reductase 2 deficiency","volume":"90","author":"Thigpen","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(98)11282-5_bib20","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(98)11282-5_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.274.5291.1371","article-title":"Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search","volume":"274","author":"Smith","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0140-6736(98)11282-5_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/514853","article-title":"Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25","volume":"61","author":"McIndoe","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(98)11282-5_bib23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/301879","article-title":"Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42\u00b72-43","volume":"62","author":"Berthon","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0140-6736(98)11282-5_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/2477","article-title":"Evidence for a prostate cancer susceptibility locus on the X chromosome","volume":"20","author":"Xu","year":"1998","journal-title":"Nat Genet"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698112825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698112825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T22:27:53Z","timestamp":1556317673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673698112825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":24,"journal-issue":{"issue":"9183","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["S0140673698112825"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(98)11282-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}